Page 30 - GPD-4-3
P. 30

Gene & Protein in Disease                                        TNFA polymorphism and risk of endometriosis




                   HWE   (FDR)  0.78  0.78  0.78  NA  0.78  0.78  0.97  0.97  *0.0008  0.97  NA  NA  1  0.97  0.91  0.97  *<0.05  *<0.05  0.63  0.63  NA  NA  0.63  0.63  0.22  0.46  NA  NA  0.22  *0.002  0.46  (Cont’d...)
             Table 3. Characteristics of studies eligible for meta‑analysis of tumor necrosis factor‑alpha variants( ‑238 G>A, ‑308 G>A, ‑850 C>T, ‑857 C>T, ‑863 C>A, and ‑1031
                      HW  62  178  168  27  135  49  180  80  174  65  84  127  171  2  60  120  112  173  102  127  121  166  13  99
                   Control  HT  7  24  7  31  14  18  22  18  5  0  21  21  15  77  2  55  46  67  36  45  42  78  46  44


                      HR  0  0  0   7  0  2  0  8  0      0  2  2  0  6  3  8  7     8  5  8  2       4  6  7

                      HW  84  56  127  36  137  73  60  86  125  65  160  131  159  4  63  83  89  172  102  90  98  148  7  114

                   Case  HT  8  14  1  22  11  15  10  25  1  0  64  18  24  79  0  43  32  67  43  30  23  92  51  32


                      HR  0  0  1  No data given  7  2  4  0  9  0  No data given  No data given  0  27  1  0  27  2  4  2  No data given  No data given  7  3  9  2  No data given  No data given  6  7  4



                   Genotyping   tech  PCR-RFLP  Multiplex  PCR-RFLP  SNP-Array  PCR-RFLP  PCR-RFLP  PCR-RFLP  Multiplex  PCR-RFLP  PCR-RFLP  SNP-array  Sequencing  PCR-RFLP  PCR-RFLP  PCR-RFLP  PCR-RFLP  PCR-RFLP  PCR-RFLP  PCR-RFLP  PCR-PHFA  SNP-array  PCR-RFLP  PCR-RFLP  PCR-RFLP  PCR-RFLP  PCR-PHFA  PCR-RFLP  SNP-array  PCR-RFLP  PCR-RFLP  PCR-RFLP





                   Case/  Control  92/69  70/202  129/175  958/959  65/65  150/149  92/69  70/202  120/106  129/175  958/959  24/18  65/65  251/107  150/149  183/186  110/50  65/65  129/175  123/165  958/959  210/202  246/248  150/149  129/175  123/165  210/202  958/959  246/248  65/65  150/149



                   Source of   control  HB  NG  PB  HB  HB  HB  HB  NG  HB  PB  HB  HB  HB  HB  HB  HB  HB  HB  PB  HB  HB  HB  HB  HB  PB  HB  HB  HB  HB  HB  HB


                   Type of   study  CC  CC  CC  CH  CC  CC  CC  CC  CC  CC  CH  CC  CC  CC  CC  CC  CC  CC  CC  CC  CH  CC  CC  CC  CC  CC  CC  CH  CC  CC  CC




                   Ethnicity  Caucasian  Asian  Asian  Caucasian  Asian  Asian  Caucasian  Asian  Asian  Asian  Caucasian  Caucasian  Asian  Caucasian  Asian  Caucasian  Asian  Asian  Asian  Asian  Caucasian  Asian  Asian  Asian  Asian  Asian  Asian  Caucasian  Asian  Asian  Asian


                T>C0 and their association with the risk of endometriosis
                   Country  Australia  South Korea  Japan  Australia  Iran  Iran  Australia  South Korea  Taiwan  Japan  Australia  USA  Iran  Russia  Iran  Mexico  India  Iran  Japan  Japan  Australia  Korea  South Korea  Iran  Japan  Japan  Korea  Australia  South Korea  Iran  Iran



                   YOP   2002  2002  2004  2007  2015  2019  2002  2002  2002  2004  2007  2012  2015  2018  2019  2022  2010  2014  2004  2004  2007  2008  2008  2019  2004  2004  2008  2007  2008  2014  2019






                   Authors  Wieser et al.  17  Lee et al.  11  Asghar et al.  21  Zhao et al.  12  Abutorabi et al.  26  Babaabasi et al.  27  Wieser et al.  17  Lee et al.  11  Hsieh et al.  13    Asghar et al.  21  Zhao et al.  12   Rotman et al.  14  Abutorabi et al.  26  Kublinsky et al.  16  Babaabasi et al.  27  Mier-Cabrera et al.  28  Lakshhmi et al.  31  Mardanian et al.  29  Asghar et al.  21  Teramoto et al.  30  Zhao et al.  12  Chae et al.  18  Lee et al.  15


                   No.   1  2  3  4  5  6  1  2  3  4  5  6  7  8  9  10  1  2  1  2  3  4  5  6  1  2  3  4  5  6  7



                   Variant  -238 G>A     -308 G>A                    -850 C>T  -857 C>T    -863 C>A




            Volume 4 Issue 3 (2025)                         4                               doi: 10.36922/gpd.5204
   25   26   27   28   29   30   31   32   33   34   35